A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.

导出 LinkOut

翻译打印收藏纠错

作者： Hyun Jin,Park ^[1] ; Gun-Young,Jang ^[1] ; Young Seob,Kim ^[1] ; Jung Hwa,Park ^[1] ; Sung Eun,Lee ^[1] ; Manh-Cuong,Vo ^[2] ; Je-Jung,Lee ^[2] ; Hee Dong,Han ^[1] ; In Duk,Jung ^[1] ; Tae Heung,Kang ^[3] ; Yeong-Min,Park ^[4]

作者单位： Department of Immunology, KU Open Innovation Center, School of Medicine, Konkuk University, 268, Chungwondaero, Chungju, 274798, South Korea. ^[1] Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun-gun, Jeollanam-do, 58128, South Korea. ^[2] Department of Immunology, KU Open Innovation Center, School of Medicine, Konkuk University, 268, Chungwondaero, Chungju, 274798, South Korea. kangiron@kku.ac.kr. ^[3] Department of Immunology, KU Open Innovation Center, School of Medicine, Konkuk University, 268, Chungwondaero, Chungju, 274798, South Korea. immun3023@kku.ac.kr. ^[4]

关键词 40S ribosomal protein S3 (RPS3)DC based vaccine Dendritic cell (DC)Toll-like receptor 4 (TLR4)

主题词佐剂, 免疫(Adjuvants, Immunologic);动物(Animals);抗原呈递细胞(Antigen-Presenting Cells);癌症疫苗(Cancer Vaccines);细胞因子类(Cytokines);树突细胞(Dendritic Cells);女(雌)性(Female);HMGB1蛋白质(HMGB1 Protein);人类(Humans);免疫记忆(Immunologic Memory);配体(Ligands);小鼠(Mice);肿瘤(Neoplasms);蛋白质结合(Protein Binding);重组蛋白质类(Recombinant Proteins);核糖体蛋白质类(Ribosomal Proteins);信号传导(Signal Transduction);T淋巴细胞亚群(T-Lymphocyte Subsets);Toll样受体4(Toll-Like Receptor 4)

DOI 10.1186/s40425-019-0539-7

PMID 30819254

发布时间 2020-05-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Journal for immunotherapy of cancer

2019年7卷1期

60页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.

Journal for immunotherapy of cancer

相似文献

Journal for immunotherapy of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.

Journal for immunotherapy of cancer

相似文献

Journal for immunotherapy of cancer

相关期刊

检索历史清除